Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Stepan (SCL) Research & Development (2016 - 2025)

Stepan's Research & Development history spans 16 years, with the latest figure at $15.7 million for Q4 2025.

  • For Q4 2025, Research & Development rose 13.85% year-over-year to $15.7 million; the TTM value through Dec 2025 reached $59.3 million, up 6.47%, while the annual FY2025 figure was $59.3 million, 6.47% up from the prior year.
  • Research & Development reached $15.7 million in Q4 2025 per SCL's latest filing, up from $14.2 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $17.1 million in Q4 2021 to a low of $13.5 million in Q3 2024.
  • Average Research & Development over 5 years is $15.2 million, with a median of $15.1 million recorded in 2021.
  • Peak YoY movement for Research & Development: dropped 15.49% in 2023, then grew 13.85% in 2025.
  • A 5-year view of Research & Development shows it stood at $17.1 million in 2021, then dropped by 2.99% to $16.5 million in 2022, then fell by 7.39% to $15.3 million in 2023, then fell by 9.96% to $13.8 million in 2024, then rose by 13.85% to $15.7 million in 2025.
  • Per Business Quant, the three most recent readings for SCL's Research & Development are $15.7 million (Q4 2025), $14.2 million (Q3 2025), and $14.7 million (Q2 2025).